dc.contributor.author | Wilkins, A | |
dc.contributor.author | Hall, E | |
dc.contributor.author | Lewis, R | |
dc.contributor.author | Gribble, H | |
dc.contributor.author | Melcher, A | |
dc.contributor.author | Huddart, R | |
dc.contributor.author | RE-ARM Trial Management Group, | |
dc.date.accessioned | 2021-12-15T16:02:56Z | |
dc.date.available | 2021-12-15T16:02:56Z | |
dc.date.issued | 2022-07-01 | |
dc.identifier.citation | Clinical Oncology | |
dc.identifier.issn | 0936-6555 | |
dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/4927 | |
dc.language | eng | |
dc.language.iso | eng | |
dc.publisher | ELSEVIER SCIENCE LONDON | |
dc.rights.uri | https://www.rioxx.net/licenses/all-rights-reserved | |
dc.title | RE-ARMing the Immune Response to Bladder Cancer with Radiotherapy. | |
dc.type | Journal Article | |
dcterms.dateAccepted | 2021-12-10 | |
rioxxterms.version | AM | |
rioxxterms.licenseref.uri | https://www.rioxx.net/licenses/all-rights-reserved | |
rioxxterms.licenseref.startdate | 2021-12-10 | |
rioxxterms.type | Journal Article/Review | |
dc.relation.isPartOf | Clinical Oncology | |
pubs.notes | Not known | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Clinical Trials & Statistics Unit | |
pubs.publication-status | Accepted | |
pubs.embargo.terms | Not known | |
icr.researchteam | Clinical Trials & Statistics Unit | |
dc.contributor.icrauthor | Corbett, Anna | |
dc.contributor.icrauthor | Hall, Emma | |
dc.contributor.icrauthor | Lewis, Rebecca | |
dc.contributor.icrauthor | Melcher, Alan | |
dc.contributor.icrauthor | Huddart, Robert | |